BioSpace News Archive

PARP Inhibitors are the medications, which hinder the chemical called poly ADP ribose polymerase. PARP inhibitors produced for treating a few maladies, the most critical one is malignant growth.

Increasing prevalence of chronic ulcers such as diabetes, foot ulcers, and other conditions such as surgical wounds is expected fuel demand for effective wound care

Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, announced that Greg Korbel, Senior Vice President and Chief Business Officer, will present a corporate update at the 2021 Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 3:45 p.m. ET.

OTC Markets Group Inc., operator of financial markets for 11,000 U.S. and global securities, announced Nova Leap Health Corp., an acquisitive home health care services company, has qualified to trade on the OTCQX® Best Market.

Laboratory and pre-clinical models of whole-lung engineering inform roadmap for building a functional lung alveolus, which is the key building block for making a functional lung Data presented at 38th Annual Meeting of the Japanese Association for Chest Surgery

Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.

Application of comfortable and functional waveform to relieve pain associated with temporomandibular joint dysfunction.

Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), an oncology company seeking to drive shareholder returns by focusing on the patient, today announced that Jon Wigginton, M.D. is stepping down from his day-to-day role as Chief Medical Officer, and will assume the role of Chairman of the company’s Scientific Advisory Board (SAB) and Senior Advisor to the CEO.

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in The Benchmark Company Healthcare House Call Virtual Video 1x1 Investor Conference on Wednesday, May 26, 2021 .

Sterility refers to the non-appearance of viable microorganisms. This testing confirms that products are free from any kind of viable microorganisms.